Literature DB >> 26154665

The Complexities of the Diagnosis and Management of Kawasaki Disease.

Anne H Rowley1.   

Abstract

Kawasaki disease (KD) must be considered in the differential diagnosis of any child with fever for 4 to 5 days and compatible clinical and laboratory features, and in any infant with prolonged fever and compatible laboratory features, even in the absence of the classic clinical signs. Prompt therapy is required, because delayed or unrecognized KD can lead to lifelong heart disease or death in previously healthy children. Most children with KD respond to a single 2 g/kg dose of intravenous gammaglobulin with oral aspirin, but a small subset require additional therapies to resolve the clinical illness.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acquired pediatric heart disease; Coronary artery aneurysm; Myocardial infarction; Prolonged fever; Systemic inflammation

Mesh:

Substances:

Year:  2015        PMID: 26154665      PMCID: PMC4552602          DOI: 10.1016/j.idc.2015.05.006

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  50 in total

1.  Repeated systematic surveillance of Kawasaki disease in Ontario from 1995 to 2006.

Authors:  Yahui T Lin; Cedric Manlhiot; Joyce C Y Ching; Ra K Han; Lynne E Nield; Rejane Dillenburg; Dion Pepelassis; Lillian S Lai; John F Smythe; Nita Chahal; Rae S M Yeung; Brian W McCrindle
Journal:  Pediatr Int       Date:  2010-10       Impact factor: 1.524

2.  Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease.

Authors:  Beth F Printz; Lynn A Sleeper; Jane W Newburger; L LuAnn Minich; Timothy Bradley; Meryl S Cohen; Deborah Frank; Jennifer S Li; Renee Margossian; Girish Shirali; Masato Takahashi; Steven D Colan
Journal:  J Am Coll Cardiol       Date:  2011-01-04       Impact factor: 24.094

3.  A half-century of autopsy results--incidence of pediatric vasculitis syndromes, especially Kawasaki disease.

Authors:  Kei Takahashi; Toshiaki Oharaseki; Yuki Yokouchi; Hitomi Yamada; Kazutoshi Shibuya; Shiro Naoe
Journal:  Circ J       Date:  2012-02-07       Impact factor: 2.993

4.  Kawasaki disease in Israel.

Authors:  Maskit Bar-Meir; Ziona Haklai; Michael Dor
Journal:  Pediatr Infect Dis J       Date:  2011-07       Impact factor: 2.129

5.  Racial/ethnic differences in the incidence of Kawasaki syndrome among children in Hawaii.

Authors:  Robert C Holman; Krista Y Christensen; Ermias D Belay; Claudia A Steiner; Paul V Effler; Jill Miyamura; Susan Forbes; Lawrence B Schonberger; Marian Melish
Journal:  Hawaii Med J       Date:  2010-08

6.  Cyclosporin A treatment for Kawasaki disease refractory to initial and additional intravenous immunoglobulin.

Authors:  Hiroyuki Suzuki; Masaru Terai; Hiromichi Hamada; Takafumi Honda; Tomohiro Suenaga; Takashi Takeuchi; Norishige Yoshikawa; Shoichi Shibuta; Masakazu Miyawaki; Ko Oishi; Hironobu Yamaga; Noriyuki Aoyagi; Seiji Iwahashi; Ritsuko Miyashita; Yoshihiro Onouchi; Kumiko Sasago; Yoichi Suzuki; Akira Hata
Journal:  Pediatr Infect Dis J       Date:  2011-10       Impact factor: 2.129

7.  Reaction at the bacillus Calmette--Guérin inoculation site in patients with Kawasaki disease.

Authors:  Chi-Chieh Lai; Pi-Chang Lee; Chih-Chien Wang; Be-Tau Hwang; C C Laura Meng; Ming-Chih Tsai
Journal:  Pediatr Neonatol       Date:  2012-12-03       Impact factor: 2.083

8.  Recognition of a Kawasaki disease shock syndrome.

Authors:  John T Kanegaye; Matthew S Wilder; Delaram Molkara; Jeffrey R Frazer; Joan Pancheri; Adriana H Tremoulet; Virginia E Watson; Brookie M Best; Jane C Burns
Journal:  Pediatrics       Date:  2009-05       Impact factor: 7.124

9.  Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007.

Authors:  Robert C Holman; Ermias D Belay; Krista Y Christensen; Arianne M Folkema; Claudia A Steiner; Lawrence B Schonberger
Journal:  Pediatr Infect Dis J       Date:  2010-06       Impact factor: 2.129

Review 10.  Epidemiology of Kawasaki disease in Asia, Europe, and the United States.

Authors:  Ritei Uehara; Ermias D Belay
Journal:  J Epidemiol       Date:  2012-02-04       Impact factor: 3.211

View more
  8 in total

Review 1.  Kawasaki disease: etiopathogenesis and novel treatment strategies.

Authors:  Shreya Agarwal; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2016-09-13       Impact factor: 4.473

2.  Novel Echocardiographic Indices for Assessing the Left Main Coronary Artery in Children With Kawasaki Disease.

Authors:  Elaheh Malakan Rad; Iran Malekzadeh; Vahid Ziaee; Raheleh Rajabi; Zohreh Shahabi
Journal:  Iran J Pediatr       Date:  2016-08-01       Impact factor: 0.364

3.  An Unexpected Fever Post Serogroup B Meningococcal Sepsis.

Authors:  Daniele Donà; Elisa Gnoato; Carlo Giaquinto; Carlo Moretti
Journal:  Pediatr Rep       Date:  2016-11-17

4.  Giant coronary artery aneurysms in a 12-week-old infant with incomplete Kawasaki disease.

Authors:  Lucy Guile; Simon Parke; Alison Kelly; Robert Tulloh
Journal:  BMJ Case Rep       Date:  2018-03-28

5.  [Atypical and incomplete Kawasaki disease in pediatric age].

Authors:  Norberto Sotelo-Cruz
Journal:  Bol Med Hosp Infant Mex       Date:  2016-05-31

6.  Exploring the Mechanism of Aspirin in the Treatment of Kawasaki Disease Based on Molecular Docking and Molecular Dynamics.

Authors:  Li Xiong; Junfeng Cao; Yixin Qiu; Yinyin Fu; Siyi Chen; Mengjia He; Shengyan Chen; Wei Xie; Xingyu Yang; Chaochao Wang; Mei Wu; Hengxiang Xu; Yijun Chen; Xiao Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-12       Impact factor: 2.650

7.  A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?

Authors:  Wei Li; Xiufang He; Li Zhang; Zhouping Wang; Yanfei Wang; Huimei Lin; Jia Yuan; Xiaofei Xie; Youzhen Qin; Ping Huang
Journal:  Cardiovasc Ther       Date:  2021-06-18       Impact factor: 3.023

Review 8.  Controversies in diagnosis and management of Kawasaki disease.

Authors:  Rakesh Kumar Pilania; Dharmagat Bhattarai; Surjit Singh
Journal:  World J Clin Pediatr       Date:  2018-02-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.